Difficulty: Medium
Average Score: 76%
Practice
If a fetus is known or anticipated to have low surfactant levels, the mother should be given corticosteroids at what time period to to possibly increase production of surfactant?
Correct answer
B
Rationale
In the context of managing low surfactant levels in a fetus, administering corticosteroids like betamethasone 24-48 hours before preterm delivery is crucial. This timing allows the corticosteroids to stimulate the production of surfactant in the fetal lungs, aiding in lung maturation and reducing the risk of respiratory distress syndrome.
Option A (More than 7 days before birth) is incorrect because administering corticosteroids too far in advance may not provide the immediate benefit needed to boost surfactant levels right before birth.
Option C (At 35 to 36 weeks gestation) is incorrect because while this timeframe is close to full term, it may not allow enough time for the corticosteroids to have their maximum effect on surfactant production before birth occurs.
Option D (At the time of birth) is incorrect as administering corticosteroids at this late stage does not allow sufficient time for the medication to stimulate surfactant production, which is critical for neonatal lung function.
Understanding the timing of corticosteroid administration in relation to preterm birth is essential for nursing and medical professionals caring for pregnant individuals at risk of delivering preterm infants with low surfactant levels. By selecting the correct option, healthcare providers can optimize fetal lung development and improve neonatal outcomes related to oxygenation and respiratory function.
Option A (More than 7 days before birth) is incorrect because administering corticosteroids too far in advance may not provide the immediate benefit needed to boost surfactant levels right before birth.
Option C (At 35 to 36 weeks gestation) is incorrect because while this timeframe is close to full term, it may not allow enough time for the corticosteroids to have their maximum effect on surfactant production before birth occurs.
Option D (At the time of birth) is incorrect as administering corticosteroids at this late stage does not allow sufficient time for the medication to stimulate surfactant production, which is critical for neonatal lung function.
Understanding the timing of corticosteroid administration in relation to preterm birth is essential for nursing and medical professionals caring for pregnant individuals at risk of delivering preterm infants with low surfactant levels. By selecting the correct option, healthcare providers can optimize fetal lung development and improve neonatal outcomes related to oxygenation and respiratory function.